Mirae Asset Global ETFs Holdings
KRYS icon

Mirae Asset Global ETFs Holdings’s Krystal Biotech KRYS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.89M Buy
15,121
+2,167
+17% +$577K 0.01% 896
2025
Q4 		$3.2M Sell
12,954
-336
-3% -$70.7K ﹤0.01% 958
2025
Q3 		$2.35M Sell
13,290
-1,993
-13% -$298K ﹤0.01% 1071
2025
Q2 		$2.1M Sell
15,283
-610
-4% -$89.6K ﹤0.01% 1070
2025
Q1 		$2.87M Buy
15,893
+688
+5% +$116K 0.01% 952
2024
Q4 		$2.39M Sell
15,205
-181
-1% -$32.1K 0.01% 1038
2024
Q3 		$2.79M Buy
15,386
+2,792
+22% +$538K 0.01% 958
2024
Q2 		$2.31M Buy
+12,594
New +$2.11M 0.01% 1014

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's KRYS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Krystal Biotech (KRYS) stake by 17% in Q1 2026, buying an estimated $577K and bringing the position to 15,121 shares worth $3.89M. The position accounts for 0.01% of the portfolio, ranked #896.

Mirae Asset Global ETFs Holdings first reported a position in KRYS in Q2 2024 and has held it in 8 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 15,121 shares of Krystal Biotech worth $3.89M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 2,167 Krystal Biotech shares in Q1 2026, an estimated $577K.
  • Krystal Biotech made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #896 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Krystal Biotech in Q2 2024 and has held it in 8 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.